Sen. Jerry Moran (R-KS) Secures $36M in Funds for KU Cancer Center

Posted January 21, 2026

The University of Kansas Cancer Center has secured $36 million in funding from U.S. Senator Jerry Moran (R-Kansas).

Moran, the chairman of the Senate Appropriations Subcommittee on Commerce, Justice, and Science (CJS), announced Congress approved the funding as part of a three-bill appropriations package, which now goes to the President’s desk to be signed into law.

“With these federal resources, The University of Kansas Cancer Center will be able to complete construction on this new, state-of-the-art cancer center and bring us closer to opening its doors for groundbreaking cancer research,” Morgan said in a release. “This facility will expand the cancer services and research provided in Kansas and across the Midwest, saving lives and bringing us closer to finding a cure for cancer.”

Moran has secured over $100M in funding for the center.

In May, The University of Kansas Health System broke ground on its new cancer center. The facility is poised to be one of the health system’s largest funded projects, estimated to cost over $329 million. The center is located on the 39th and Rainbow campus in Kansas City and has been developed in a phased construction plan.

The cancer center supports cellular therapy and houses a cellular therapeutics Good Manufacturing Practice (GMP) laboratory that will expedite CAR T-cell therapy, being one of the only centers in the region to offer all seven FDA-approved CAR T-cell therapies.

“Today marks another milestone in our effort to strengthen the KU Cancer Center’s status among the best cancer centers in the nation,” KU Chancellor Douglas Girod said in the release.

Moran has also requested an additional $10 million for The University of Kansas Health System in the LHHS FY2026 Appropriations bill to purchase equipment for the center. The legislation is expected to be considered by the House by next week before consideration by the Senate, according to the release.